Abstract

BackgroundSulfotransferase 1A1 (SULT1A1) gene expression is tissue specific, with little to no expression in normal breast epithelia. Expression in breast tumors has been documented, but the transcriptional regulation of SULT1A1 in human breast tissue is poorly understood. We identified Nuclear Factor I (NFI) as a transcription factor family involved in the regulation of SULT1A1 expression.MethodsTranscription Factor Activation Profiling Plate Array assay was used to identify the possible transcription factors that regulate the gene expression of SULT1A1in normal breast MCF-10A cells and breast cancer ZR-75-1 cells. Expression levels of NFI-C and SULT1A1 were determined by real-time RT-PCR using total RNA isolated from 84 human liver samples. Expression levels of SULT1A1, NFI-A, NFI-B, NFI-C, and NFI-X were also determined in different human breast cancer cell lines (MCF-7, T-47D, ZR-75-1, and MDA-MB-231), in the transformed human epithelial cell line MCF-10A, and in ZR-75-1 cells that were transfected with siRNAs directed against NFI-A, NFI-B, NFI-C, or NFI-X for 48 h. The copy numbers of SULT1A1 in cell lines ZR-75-1, MCF-7, T-47D, MDA-MB-231, and MCF-10A were determined using a pre-designed Custom Plus TaqMan® Copy Number kit from Life Technologies.ResultsIn normal human liver samples, SULT1A1 mRNA level was positively associated with NFI-C. In different human breast cancer and normal epithelial cell lines, SULT1A1 expression was positively correlated with NFI-B and NFI-C. SULT1A1 expression was decreased 41% and 61% in ZR-75-1 cells treated with siRNAs against NFI-A and NFI-C respectively. SULT1A1 gene expression was higher in cells containing more than one SULT1A1 copy numbers.ConclusionsOur data suggests that SULT1A1 expression is regulated by NFI, as well as SULT1A1 copy number variation in human breast cancer cell lines. These data provide a mechanistic basis for the differential expression of SULT1A1 in different tissues and different physiological states of disease.

Highlights

  • Sulfotransferase 1A1 (SULT1A1) gene expression is tissue specific, with little to no expression in normal breast epithelia

  • To test if this is true in cultured cells, the mRNA levels of SULT1A1 were determined in the breast cancer cell lines ZR-75-1, MCF-7, T-47D, MDA-MB-231 and the human transformed breast epithelial cell line MCF-10A with relative quantitative RT-PCR (qRT-PCR)

  • To determine the relationship between Nuclear Factor I (NFI) or GATA transcription factor 1 (GATA-1) and SULT1A1, mRNA levels of each were measured using total RNA isolated from 84 normal human liver samples

Read more

Summary

Introduction

Sulfotransferase 1A1 (SULT1A1) gene expression is tissue specific, with little to no expression in normal breast epithelia. Expression in breast tumors has been documented, but the transcriptional regulation of SULT1A1 in human breast tissue is poorly understood. TAM is the only FDAapproved breast cancer chemoprevention agent, as its use is associated with decreased occurrence of contralateral breast cancer in patients treated with adjuvant TAM [2]. Both the therapeutic efficacy and adverse effects of TAM vary considerably among individuals [3]. It has been shown that gene expression/protein activity levels of SULT1A1 affect the efficacy of TAM treatment [15,16,17,18]. Given the role that SULT1A1 plays in drug efficacy and in individual susceptibility to disease, it is important to elucidate the factors regulating the differential expression of SULT1A1

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call